Clinical trial
Fluphenazine Decanoate for Psoriasis
NCT00356200 · Tufts Medical Center, Other · Terminated
Key facts
| NCT number | NCT00356200 |
|---|---|
| Title | Fluphenazine Decanoate for Psoriasis |
| Official title | Ascending-Dose, Double-Blind, Placebo-Controlled, Bilateral Study of Intralesional Fluphenazine Decanoate in Psoriasis |
| Lead sponsor | Tufts Medical Center, Other |
| Collaborators | Immune Control Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Psoriasis |
| Intervention type | Drug |
| Interventions | Fluphenazine Decanoate, Placebo |
| Enrollment | 10 |
| Start date | Jul 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Sep 1, 2008 |
| First posted | Jul 25, 2006 |
| Last update posted | Dec 22, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: